Judge queries time for child migrant review
A judge said yesterday it appeared the Trump administration could identify potentially thousands of children who were separated from their families at the border in much less time than the one to two years officials want to complete the work, though he was reluctant to impose a deadline.
US District Judge Dana Sabraw asked lawyers for the administration and for the American Civil Liberties Union to reach an agreement before an April 24 hearing that will include Jonathan White, a US Health and Human Services Department official who led a previous effort that reunited more than 2700 children with their families.
The Justice Department has said it will take as long as two years to review about 47,000 cases involving unaccompanied children who were taken into US government custody between July 1, 2017, and June 25, 2018 – the day before Sabraw halted the general practice of splitting families and ordered that children in custody be reunited with their parents.
The ACLU said in a court filing on Tuesday that the government’s timetable showed ‘‘callous disregard’’ for families and asked the judge to order that all separated families be identified in three months. Sabraw said he was unprepared to set deadlines and that the two sides should quickly develop a joint plan. If those efforts fail, he said he would go the ‘‘old-fashioned way’’ of entertaining competing arguments and deciding himself, calling that route ‘‘a great disservice.’’
Last year, the judge set tight deadlines to reunify more than 2700 children, which was largely accomplished through frequent and sometimes contentious hearings in his San Diego courtroom.
In January, the Health and Human Services Department’s internal watchdog reported that thousands more children may have been separated from their families since the summer of 2017. The department’s inspector general said the precise number was unknown.
Sabraw ruled last month that he could hold the government accountable for those separated before his June order and asked the government to submit a proposal.
White saidearlier this month that the sheer volume of 47,000 cases makes the job different than identifying who among 12,000 children in custody at the time of the judge’s June order had been separated from their parents. – AP After years of advocacy by injured patients, the US Food and Drug Administration has ordered the makers of mesh devices for the repair of pelvic organ prolapse, or POP, to remove the products from the US market, including mesh sold by Coloplast A/S and Boston Scientific Corp.
Women who were scheduled to have mesh implanted to treat pelvic organ prolapse will need to discuss other treatment options with their doctors, the FDA said yesterday.
The decision does not apply to similar mesh products used to treat stress urinary incontinence.
Organisers with the patient-activist group Medical Device Problems offered lukewarm praise for the FDA’s decision
The group said it took too long to happen and did not go far enough.
‘‘These mesh devices were on the market for over 20 years, leaving tens of thousands of women to live with permanent disabilities and disfigurement. We feel the announcement, while a step in the right direction, also does not go far enough; it does not address other mesh devices that are causing similar life-altering injuries,’’ wrote Amanda Dykeman, the Illinois-based founder of Medical Device Problems.
Manufacturers say the decision to remove transvaginal mesh products for POP may have negative effects for some patients.
‘‘We are deeply disappointed by the FDA’s decision on our premarket approval applications,’’ Boston Scientific spokeswoman Kate Haranis said. The company believes that ‘‘the inaccessibility of these products will severely limit treatment options for the 50 per cent of women in the US who will suffer from pelvic organ prolapse during their lives.’’ – TNS